RICHARD CAPDEVILA: Open Payments
NPI 1518468941 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 69 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $531 · 2025 $1,260
Food & beverage: $1,242Education: $17
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $201 |
| Lilly USA, LLC | 10 | $160 |
| Abbott Laboratories | 6 | $130 |
| Novo Nordisk Inc | 6 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $121 |
| PFIZER INC. | 4 | $82 |
| Amphastar Pharmaceuticals, Inc. | 3 | $72 |
| Exact Sciences Corporation | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
Products named: OTEZLA, FREESTYLE LIBRE 3, MOUNJARO, The Cologuard Plus Collection Kit, ELIQUIS, SHINGRIX, JARDIANCE, GEMTESA.
Industry payments across FL — which companies pay providers there.
